NCT04549376 - Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

October 20, 2020

Study Completion Date

October 30, 2020

Conditions

COVID19

Interventions

DRUG

Povidone-Iodine 0.4% NI

Povidone iodine (PVP-I) nasal irrigation at concentration of 0.4%

DRUG

Povidone-Iodine 0.5% NI

Povidone iodine (PVP-I) nasal irrigation at concentration of 0.5%

DRUG

Povidone-Iodine 0.6% NI

Povidone iodine (PVP-I) nasal irrigation at concentration of 0.6%

DRUG

Povidone-Iodine 0.5% NS

Povidone iodine (PVP-I) nasal spray at concentration of 0.5%

DRUG

Povidone-Iodine 0.6% NS

Povidone iodine (PVP-I) nasal spray at concentration of 0.6%

OTHER

Placebo comparator: DW-NI

Nasal irrigation will be provided by Distilled water

OTHER

Placebo comparator: DW-NS

Nasal spray will be provided by Distilled water

Trial Locations (1)

Dhaka Medical College, Dhaka